DEA Schedule CII

Strength

3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1

Manufacturer

Alvogen Inc.

NDC

47781017801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207388

On Market Since

7/28/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-6.8%

3M

-15.6%

6M

-1.9%

1Y

-8.4%

3Y

-26.4%

5Y

-26.5%

All

-22.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.